Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 10 mm (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 10 mm (Expand Search)
-
8041
-
8042
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes
Published 2015“…Trends toward lower glycemic variability (83.1±18.9 to 75.6±28.6mg/dL, p = 0.06) and little change in glycemic stability (10.8±3.6 to 10.3±4.5mg/dL/h, p = 0.51) were observed. …”
-
8043
Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre...
Published 2023“…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
-
8044
Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre...
Published 2023“…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
-
8045
Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre...
Published 2023“…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
-
8046
Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre...
Published 2023“…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
-
8047
-
8048
-
8049
-
8050
-
8051
-
8052
-
8053
Intraperitoneal administration with streptavidin benefits an establishment of a CD-1 mice model for <i>P</i>. <i>aeruginosa</i>, of which the plasma (and organ contents) biotin lev...
Published 2023“…<i>aeruginosa</i>, the model of CD-1 mice is subjected for an intraperitoneal administration with streptavidin (2 mg/kg) as recently Carfrae <i>et al</i>. [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011110#ppat.1011110.ref015" target="_blank">15</a>] recommended, which is supposed to reduce the biotin levels in mouse plasma and other organ contents. …”
-
8054
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
8055
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
8056
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
8057
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
8058
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
8059
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
8060
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”